Translations:Lipid-lowering agent/1/en: Difference between revisions
Importing a new version from external source |
Importing a new version from external source |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Drug List/ja}} | {{Drug List/ja}} | ||
{{PathNav|Medication|frame=1}} | {{PathNav|Medication|frame=1}} | ||
{| class="wikitable sortable" style="width:100%" | |||
|+脂質降下薬(その他) | |||
|- | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!創薬/開発 | |||
!備考 | |||
|- | |||
|[[Omega-3 acid ethyl esters/ja]] | |||
|[https://www.takedamed.com/medicine/detail?medicine_id=601 ロトリガ](武田薬品) ([https://pins.japic.or.jp/pdf/newPINS/00060775.pdf PI]) ([https://www.takedamed.com/medicine/detail?medicine_id=601&setpopflage=true IF]) | |||
|販売 | |||
|[[Takeda Pharmaceutical Company]] | |||
| | |||
|- | |||
|[[Ethyl eicosapentaenoic acid/ja]] | |||
|[https://med.mochida.co.jp/medicaldomain/circulatory/epadel/index.html エパデール](持田製薬) ([https://med.mochida.co.jp/txt/pdf/epa-s_n22.pdf PI]) ([https://med.mochida.co.jp/interview/epas_n22.pdf IF]) | |||
|販売 | |||
|[[Mochida Pharmaceutical]] | |||
| | |||
|- | |||
|} | |||
'''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. | '''Lipid-lowering agents''', also sometimes referred to as '''hypolipidemic agents''', '''cholesterol-lowering drugs''', or '''antihyperlipidemic agents''' are a diverse group of [[pharmacology|pharmaceuticals]] that are used to lower the level of lipids and lipoproteins such as cholesterol, in the blood ([[hyperlipidemia]]). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. |